Skip to content

AESTHIA

Active
Private limited companyfounded 2021active for 4 yearsRue des Badauds 52, 1428 Braine-l'Alleud, BelgiumKBO/BCE: BE 0777.918.917
Summary

AESTHIA has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €66,955 and a net result of -€41,291. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 21% of 1,250 sector peers (NACE 86, financial year 2024). The computed 12-month bankruptcy probability is 0.4% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
€344,123total assets 2024
Equity
€66,955
Loss
-€41,291
Financial health
79 Excellent Checked score 2024
Bankruptcy probabilitywithin 12 months
0.4%
Structure
Accounts 71 days overdue0 of 1 deed read
Why 79raises riskFigures for financial year 2024 (filed 04-08-2025)Loss of €41,291 (financial year 2024)lowers riskSector: Human health activities (NACE 86)Size: total assets €344,123Show the evidence

Checked score

Score 2024
79 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 18% of its sector peers (NACE 86, micro)
Financial strength · tick = 2023
Weak
Solvency 44-32
equity 19.5% of total assets
Liquidity 60-14
short-term debt 65.6% · cash 35.5%
Profitability 11-87
return on assets -12.0%
Bankruptcy probability, 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%

About 4 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,017 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1%lowest value 12-2024: < 0.1%● unchanged vs 11-2024lowest value 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: 0.1%▲ +0.1 percentage points vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.2%▲ +0.1 percentage points vs 08-2026 10-2026: 0.4%▲ +0.2 percentage points vs 09-2026highest value
Credit of up to €5,000 on 30-day terms is acceptable
Liquidity insufficient (current ratio 0.77, compared with 1.25 in 2023; short-term debt: 65.6% and cash: 35.5% of total assets), and 80.5% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 20% on solvency, 37% on liquidity, 4% on profitability and 10% on growth.

The bankruptcy probability was computed on 09-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
−lowers risk+raises risk○neutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Figures for financial year 2024 (filed 04-08-2025)
NBB · annual accounts
lowers risk · Size: total assets €344,123
The company's size counts in the probability; how much depends on the rest of its profile.
NBB · annual accounts
raises risk · Loss of €41,291 (financial year 2024)
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 21% of 1250 sector peers (2024).
NBB · sector comparison
Position among 1250 sector peers
Solvency
better than 21%
← weakest strongest →
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 04-08-2025, 4 days later. For context: 47% of Belgian companies file late, and of those that file 1 to 90 days late, 2.0% are now in a legal situation other than normal in the KBO (such as bankruptcy, liquidation or dissolution), against 1.66% of all filers. We show this as a fact and do not score it.
NBB · 4 filings
Deviation from the deadline
2025
not confirmed
2024
4 days late
2023
8 days late
2022
25 days early
2021
24 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 4 accounts on average 3 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2024 · full…
  2. Weakest financial yearnet -€41,291
  3. Annual accounts filedfinancial year 2023 · full…

Key points

  • Caution: From profit to loss in 2024after €75,968 in 2023 -€41,291 View
  • Caution: Among the weakest 7% on net resultsector median €72,534 · 1,246 companies -€41,291 View
  • Caution: Accounts not fileddeadline was 31-07-2026 71 days late View

By topic

Financials

Financial year
2024
Total assets
€344,123
Loss
-€41,291
Solvency
19.5%
Turnover▲ 164%
Net result
20212022
Go to Financials

Timeline

Events
7
Since
2022
  1. 31-12-2023Highest result from 2021 to 2024
  2. 31-12-2023Equity above €150,000
  3. 06-07-2023Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
01-12-2021
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.